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Abstract
Obesity is a major health concern worldwide which is associated with increased risk of chronic diseases such as metabolic
syndrome, cardiovascular disease and cancer. The elucidation of the molecular mechanisms involved in adipogenesis and
obesogenesis is of essential importance as it could lead to the identification of novel biomarkers and therapeutic targets for
the development of anti-obesity drugs. MicroRNAs (miRNAs) have been shown to play regulatory roles in several biological
processes. They have become a growing research field and consist of promising pharmaceutical targets in various fields
such as cancer, metabolism, etc. The present study investigated the possible implication of miRNAs in adipose tissue during
the development of obesity using as a model the C57BLJ6 mice fed a high-fat diet. C57BLJ6 wild type male mice were fed
either a standard (SD) or a high-fat diet (HFD) for 5 months. Total RNA was prepared from white adipose tissue and was
used for microRNA profiling and qPCR. Twenty-two of the most differentially expressed miRNAs, as identified by the
microRNA profiling were validated using qPCR. The results of the present study confirmed previous results. The up-
regulation of mmu-miR-222 and the down-regulation of mmu-miR-200b, mmu-miR-200c, mmu-miR-204, mmu-miR-30a*,
mmu-miR-193, mmu-miR-378 and mmu-miR-30e* after HFD feeding has also been previously reported. On the other hand,
we show for the first time the up-regulation of mmu-miR-342-3p, mmu-miR-142-3p, mmu-miR-142-5p, mmu-miR-21, mmu-
miR-146a, mmu-miR-146b, mmu-miR-379 and the down-regulation of mmu-miR-122, mmu-miR-133b, mmu-miR-1, mmu-
miR-30a*, mmu-miR-192 and mmu-miR-203 during the development of obesity. However, future studies are warranted in
order to understand the exact role that miRNAs play in adipogenesis and obesity.
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Introduction
Obesity has emerged as an epidemic in modern societies [1] and
has detrimental effects on the quality of life and the life expectancy
of people as it increases the risk of cardiovascular disease,
metabolic syndrome and cancer [2,3].
Obesity is characterized by an excess of white adipose tissue
mass. Two types of adipose tissue are found in mammals, white
and brown adipose tissue (WAT and BAT). WAT is found below
the skin (subcutaneous WAT) and inside the abdomen (abdominal
WAT) while BAT is found in the interscapular region and axillae
in rodents and in upper chest and neck in humans. The WAT has
been characterized as an endocrine organ itself [4]. It produces
endocrine acting peptides such as leptin and is metabolically
important as WAT excess is associated with metabolic syndrome
[5,6,7]. BAT is specialized in energy expenditure and its activation
can counteract obesity [8,9,10]. Despite the research that has been
made in the field of obesity and adipocyte differentiation, the exact
mechanisms involved in these processes remain to be elucidated.
The non-coding microRNAs (miRNAs) which were discovered
in the last decade [11,12] and are currently known to post-
transcriptionally regulate genes that are involved in various
biological processes (cell growth, apoptosis, metabolism) [13,14],
have come in the spotlight of research in obesity and metabolic
syndrome [15,16,17]. The existing studies on miRNAs and obesity
indicate that these molecules may play an important role in the
development of obesity and can possibly be promising targets for
future therapeutic interventions.
A popular method to identify miRNAs that may play a role in
adipogenesis and obesogenesis is the performance of miRNA
arrays in animal (mouse) models of obesity (genetically or diet-
induced) and in preadipocyte cell-culture models that are induced
to differentiate into adipocytes [18]. In this way, miRNAs that
change significantly during these processes are identified and then
they can be checked with reference to their exact role in obesity or
adipocyte differentiation. The majority of the existing studies with
miRNA arrays in obesity and adipogenesis models [17,19,20] use
the C57BLJ6 mouse after HFD feeding for 3 months as a model.
In the present study we investigated the changes that occur in
miRNA expression in white adipose tissue after long-term (5
months) high fat diet (HFD) feeding in C57BLJ6 mice, using
miRNA profiling and qPCR. We verified previously reported
changes in miRNA expression. Moreover, we identified for the
first time some new miRNAs that change significantly during long-
term diet-induced obesity. These miRNAs could be proved to be
valuable pharmaceutical targets for anti-obesity treatment.
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Ethics statement
All animal procedures were approved by the institutional review
board of the University of Patras Medical School (approval ID 15/
2008) and were in accordance with EC Directive 86/609/EEC.
Mice
The C57BL6J wild type male mice (8 weeks old) were used.
Eight mice were fed a standard diet (SD) (10 kcal% fat) and other
eight were fed an HFD (60 kcal% fat; Research Diets, New
Brunswick, NJ) for 5 months. Mice were housed in the animal
facility of the University of Patras Medical School in temperature-,
light- and humidity-controlled rooms with a 12-h light/dark cycle.
Weight measurements were performed on a weekly basis to
confirm that the HFD-fed mice gain more weight than the SD-fed
ones. Evaluation of blood glucose levels and of insulin sensitivity
was performed as described previously [21] at the beginning and
in the end of the experiment, in both groups, so as to confirm that
the HFD-fed mice developed an obese and insulin resistant
phenotype.
White adipose tissue total RNA extraction
White adipose tissue (WAT) was excised from mice from
epididymal fat pads and was submerged immediately in RNA later
solution (Ambion, Foster City, CA). Total RNA was isolated from
WAT from SD- or HFD-fed mice using the TRIzol reagent
(Invitrogen, Carlsbad, CA), following the manufacturer’s instruc-
tions. The individual RNA samples from SD- or HFD-fed mice
were pooled for microarray experiments. The Reverse-Transcrip-
tion PCR was performed in individual samples. The quality of the
total RNA for microRNA profiling was assessed using an Agilent
2100 Bioanalyzer profile (Agilent Technologies, Santa Clara, CA).
Total RNA concentration was measured with a Nanodrop
instrument, calculating the ratio A260/A280.
microRNA profiling
One mg total RNA from sample and reference were labeled with
Hy3
TM and Hy5
TM fluorescent label, respectively, using the
miRCURY
TM LNA Array power labeling kit (Exiqon,Denmark)
following the procedure described by the manufacturer. The
Hy3
TM-labeled samples and the Hy5
TM-labeled sample were
mixed pair-wise and hybridized to the miRCURY
TM LNA array
version 10.0 (Exiqon,Denmark ), which contains capture probes
targeting all miRNAs for all species registered in the miRBASE
version 11.0 at the Sanger Institute. The hybridization was
performed according to the miRCURY
TM LNA array manual
using a Tecan HS4800 hybridization station (Tecan, Austria).
After hybridization, the microarray slides were scanned and stored
Figure 1. Differentially expressed miRNAs between control
mice (standard diet) and sample mice (high-fat diet) mice. The
SD #1 and #2 indicate technical replicates. The diagram shows the top
ranking 26 differentially expressed miRNAs based on the comparison
samples versus control. Each bar represents the fold change between
the sample mice versus the control mouse. Since slide no. 3 is a dye
swap (control vs. samples) the values have been reversed to fit slides
no. 1 and 2. A fold change .1 indicates up-regulation after HFD
feeding, whereas a fold change ,1 indicates down-regulation after HFD
feeding. SD; standard diet, HFD; high-fat diet.
doi:10.1371/journal.pone.0034872.g001
Figure 2. Unsupervised hierarchical cluster analysis diagram
based on 529 probe sets with highest variation in SD vs. HFD
mice. Color saturation is directly proportional to measured expression
ratio magnitude. Rows represent individual probe set. Columns
represent experimental sample. Red bars indicate high expression.
Green bars indicate low expression. Slides 1 and 2: control (SD) mice,
slide3: sample (HFD) mice. SD; standard diet. HFD; high-fat diet.
doi:10.1371/journal.pone.0034872.g002
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to prevent potential bleaching of the fluorescent dyes. The
miRCURY
TM LNA array microarray slides were scanned using
the Agilent G2565BA Microarray Scanner System (Agilent
Technologies, Inc., USA) and the image analysis was carried out
using the ImaGene 8.0 software (BioDiscovery, Inc., USA).
Figure 3. Three-dimensional PCA clustering. The observed samples were represented as a linear combination of the principal components with
associated gene scores. The three-dimensional PCA clustering revealed 13 miRNA clusters.
doi:10.1371/journal.pone.0034872.g003
Figure 4. K-means clustering identified 10 clusters. This non-hierarchial method initially takes the number of components of the population
equal to the final required number of clusters. In this step itself the final required number of clusters is chosen such that the points are mutually
farthest apart. Next, it examines each component in the population and assigns it to one of the clusters depending on the minimum distance. The
centroid’s position is recalculated everytime a component is added to the cluster and this continues until all the components are grouped into the
final required number of clusters. A. K-means clustering of profiles and B. Centroids.
doi:10.1371/journal.pone.0034872.g004
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normalization
Filtering was performed based on the signal intensity. Spots with
no signal above the background (flags 1 and 2) were detected and
removed. Background correction was performed to remove non-
biological contributions (‘‘background’’) to the measured signal, by
subtracting the median global background from the median local
background from the signal intensity. A threshold of 2 was set as
cut-off, meaning that spot intensity for at least one channel should
be twice as much as that of the background. Normalization was
performed using the Lowess regression algorithm, in order to
remove certain systematic biases from microarray data, such as
dye effects or intensity dependence (Fig. S1 and Fig. S2). The
positive effect from normalization is illustrated on each slide sheet
with an M-A plot before and after normalization (Fig. S3). After
normalization the spots appeared symmetrically scattered around
the horizontal line (M=0). Normalized data were extracted, pre-
processed and sorted with Microsoft Excel H.
Slide quality check using spike-in controls
Spike-in CV values were calculated between 32 replicates for
each of the spike-in controls on each slide. CVs did not exceed
30%, thus reflecting lack of spatial effects on the array (smear
across the slide) or misplacement of the grid for annotating the
spots.
Clustering
We performed clustering of the miRNAs using four methods:
Hierarchical clustering (HCL), k-means clustering, Principle
Components Analysis (PCA) and TIGR clustering (terrain
classification) using 3-dimensional representation of the clustering
results.
GEO accession numbers
Our miRNA profiling data were MIAME compliant and
deposited at the Gene Expression Omnibus (GEO) repository, with
accession numbers from GSM802367 through GSM802369 (http://
www.ncbi.nlm.nih.gov/geo/query/acc.cgi?token=btghlsqqmoessvc
&acc=GSE32419).
Reverse-Transcription (RT) and qPCR validation
The microRNA in the total RNA sample was converted to
cDNA by reverse transcription using the miRCURY
TM LNA
microRNA PCR system First-strand cDNA synthesis kit and a
microRNA-specific primer. The cDNA was amplified by real-time
PCR using SYBRH Green master mix and LNA
TM microRNA-
specific primers on a Step One Plus Instrument (Applied
Biosystems, Foster City, CA) using the designated PCR optical
tubes. The following 22 murine microRNAs were selected for
qPCR validation of their expression: mmu-miR-1, mmu-miR-21,
mmu-miR-30a*, mmu-miR-30e*, mmu-miR-122, mmu-miR-
130a, mmu-miR-133b, mmu-miR-141, mmu-miR-142-3p,
mmu-miR-142-5p, mmu-miR-146a, mmu-miR-146b, mmu-
miR-192, mmu-miR-193a-3p, mmu-miR-200b, mmu-miR-200c,
mmu-miR-203, mmu-miR-204, mmu-miR-222, mmu-miR-342-
3p, mmu-miR-378 and mmu-miR-379. All runs included no
template and RT-minus controls. A 5-fold serial dilution of pooled
cDNA samples was generated for each assay, in order to calculate
the PCR efficiency. All reactions were performed in triplicates.
Before proceeding with data normalization, a technical quality
assessment was performed based on results of the melting curve,
serial dilution curve and no-template-controls. The stability and
ranking of the endogenous controls was also calculated with the
SLqPCR algorithim. For every endogenous control gene, the pair-
wise variation with all other endogenous controls was determined
as a gene stability measurement M. An M value below 1.5 was









variance Within cluster variance
Cluster 1 96 18% 0.00666 0.05622 0.00510
Cluster 2 98 19% 0.02696 0.03822 0.01278
Cluster 3 134 25% 0.02221 0.06643 0.01069
Cluster 4 60 11% 1.49754E-7 0.05323 0.01152
Cluster 5 174 33% 0.00801 0.05567 0.00541
Cluster 6 128 24% 0.01260 0.06942 0.00403
Cluster 7 150 28% 0.00159 0.06104 0.00644
Cluster 8 52 10% 1.2731E-7 0.01901 0.01001
Cluster 9 92 17% 0.01223 0.03656 0.00835
Cluster 10 74 14% 0.01900 0.04451 0.01046
doi:10.1371/journal.pone.0034872.t001
Figure 5. Terrain (map) analysis, depicting the gene clusters, as
well as the links among the clustered genes. A. Each miRNA
cluster is depicted with a different color. B. The correlations among the
various miRNAs are depicted with lines.
doi:10.1371/journal.pone.0034872.g005
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considered unstable across the samples and unsuitable for
endogenous controls in this experiment. U6 snRNA, mmu-191,
mmu-423-5p, mmu-361 and mmu-103 were considered accept-
able and used for normalization [22]. The gene 5S rRNA was
unstable across the samples and therefore excluded from the
normalization (Fig. S4). Relative expression was performed using
the DDCt method [23,24]. Data were standardized by log2
transformation.
Gene Ontology (GO) and enrichment analysis
Gene Ontology (GO) analysis is essential in the deduction of
conclusions from microarray data. GO is a database with curated
annotations for known genes i.e. gene biological processes,
molecular functions and cellular components. Firstly, using the
miRWalk software [25] the validated target genes of the confirmed
differentially expressed miRNAs were identified. Then, GO
analysis was performed for the validated miRNA target genes,
using the Genesis 1.7.2 software [26] and the WebGestalt web-tool
(http://bioinfo.vanderbilt.edu/webgestalt) [27]). All gene defini-
tions and functions were based on the National Institute of Health
databases (http://www.ncbi.nlm.nih.gov/sites/entrez/). Further
enrichment analysis for the validated miRNA targets was also
investigated, using the WebGestalt web-tool (http://bioinfo.
vanderbilt.edu/webgestalt) [27]. The hypergeometric test, with
Bonferroni correction was used for enrichment evaluation analysis.
The R function adjP was used in order to adjust the nominal p
values of the large number of categories at the same time. The
significance level for the adjusted p-value was set at 0.01 and the
number of minimum genes for a category was set at 2.
Statistical analysis
Normality of the data distribution was checked by Kolmogorov-
Smirnov test. Differences in the expression levels between SD- and
HFD-fed mice in WAT were explored using the Mann-Whitney U
test. Numerical values are expressed as the mean6standard
deviation. Statistical significance was set at the 95% level (p,0.05).
In weight and blood glucose measurements in mice, as well as in
qPCR, the Student t-test or the one-way ANOVA followed by
Tukey’s test was used for statistical analysis. These data were
expressed as the mean6SEM or mean6standard deviation, as
described in the corresponding figure legends. Statistical signifi-
cance was set at the 95% level (p,0.05). The statistical package
GraphPad Prism was used (GraphPad Software, La Jolla, CA).
Results
In the present study, we examined the expression levels of 530
mmu-miRNAs in adipose tissue received from SD-fed mice and
compared them with the corresponding expression in adipose
tissue from HFD-fed mice for a 5-month period.
Evaluation of the obese and insulin resistant phenotype
in mice after 5 months on HFD
At the beginning of the experiment, mice were age- and weight-
matched, and thus had no statistically significant differences in
Figure 6. Figure of merit (FOM) vs. no. of clusters graph for the k-means cluster algorithm. A figure of merit is an estimate of the
predictive power of a clustering algorithm. The lower the adjusted FOM value is, the higher the predictive power of the algorithm. The value of the
adjusted FOM for the k-means run decreases steeply until the number of clusters reaches 7, after which it levels out. This suggests that, for this data
set, k-means performs optimally for 7 clusters and that any additional clusters produced will not add to the predictive value of the algorithm.
doi:10.1371/journal.pone.0034872.g006
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fed mice were significantly heavier (p,0.0001) than the SD-fed
mice, as expected (Fig. S5). Moreover, although the two mouse
groups did not have any differences in glucose tolerance and
insulin resistance at the beginning of the experiment, the HFD-fed
mice developed a significantly less glucose tolerant and more
insulin resistant phenotype than the SD-fed mice after 5 months
on the diet, as revealed by the IPGTT (Intraperitoneal Glucose
Tolerance Test) and by the IPITT (Intraperitoneal Insulin
Tolerance Test), correspondingly (Fig. S6).
MicroRNA profiling
Based on our miRCURY
TM LNA array microarray data, we
identified 26 differentially expressed miRNAs in adipose tissue
between SD and HFD mice. The following miRNAs were found
to be up-regulated in WAT after HFD feeding: mmu-miR-342-3p,
mmu-miR-222, mmu-miR-221, mmu-miR-142-3p, mmu-miR-
142-5p, mmu-miR-21, mmu-miR-335-5p, mmu-miR-146a, mmu-
miR-146b, mmu-miR-647* and mmu-miR-379. On the contrary,
the following miRNAs were down-regulated in WAT after HFD
feeding: mmu-miR-141, mmu-miR-200a, mmu-miR-200b, mmu-
miR-200c, mmu-miR-122, mmu-miR-204, mmu-miR-133b,
mmu-miR-1, mmu-miR-30a*, mmu-miR-130a, mmu-miR-192,
mmu-miR-193a-3p, mmu-miR-203, mmu-miR-378 and mmu-
miR-30e*. The log2 fold change between SD and HFD mice is
depicted in Figure 1.
Clustering
We performed Hierarchical clustering using Average Linkage
Clustering and Euclidian Distance. The condensed tree and
cluster image are depicted in Figure 2. Two big branches could be
noticed, and each one was composed of smaller ones. The first
branch (5 miRNA groups) contained mmu-miRNAs which were
under-expressed in the SD vs. the HFD mice. The second branch
was composed of 2 big groups, partitioned into 4 sub-clusters. On
the contrary, the first group of the second big branch contained
miRNAs which were over-expressed in the SD vs. the HFD mice.
Finally, the second group of the second big branch contained
Figure 7. miRNA relative expression in mice fed a standard or a high-fat diet for 5 months. The miRNA levels were measured by
quantitative RT-PCR in white adipose tissue from mice fed a standard or a high-fat diet for 5 months (n=8 for each diet type). The RT-PCR was
performed in triplicate wells for each individual sample. Bars show means6standard deviation. * p,0.0001, { p,0.001. SD; standard diet, HFD; high-
fat diet.
doi:10.1371/journal.pone.0034872.g007
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PLoS ONE | www.plosone.org 6 April 2012 | Volume 7 | Issue 4 | e34872miRNAs which were over-expressed both in SD and HFD mice.
Each group is distinct by a different coloring.
Similar clustering was performed on the principal components
(PCs) outputted by Principal Component Analysis (PCA) on the
same original data (where the gene expression measurements are
the variables and the samples are the observations). In the PCA
method, the observed samples were represented as a linear
combination of the PCs with associated gene scores. PCA showed
an even larger number of miRNA groups. Thirteen clusters could
be observed in a three-dimensional clustering (Fig. 3). The
Figure 8. Hierarchical clustering (HCL) and Principal Component Analysis (PCA). HCL (A) and PCA analysis (B) for 18 mmu-miRs validated
by qPCR. The clustering results were similar to those acquired by the miRNA profiling.
doi:10.1371/journal.pone.0034872.g008
Figure 9. Correlation between microarrays and qPCR. A. The fold changes were calculated using the DDCt comparative quantification
method. Mmu-miR-141 was not detected in ‘‘control mice’’ (SD), hence no fold change was calculated. We identified an agreement between the
microarrays and the qPCR results. B. Scatterplot and Correlation between qPCR and microarrays (Pearson’s correlation=0.888).
doi:10.1371/journal.pone.0034872.g009
Micro-RNAs in Obesity in Mice
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side in Figure 2 for an immediate comparison between them. K-
means clustering identified 10 clusters (Fig. 4). The number of
genes in each cluster, the (%) share of genes in each cluster, the
average distance from the cluster mean, the next neighbor
variance, as well as the within cluster variance, are depicted in
detail, in Table 1.
A three-dimensional TIGR clustering analysis was also
performed. The terrain (map) analysis, depicting the gene clusters,
as well as the links among the clustered genes, is depicted in
Figure 5. The predictive power of the K-means algorithm was
estimated using a figure of merit (FOM). A FOM value vs. number
of clusters was computed by removing each sample in turn from
the data set, clustering genes based on the remaining data, and
calculating the fit of the withheld sample to the clustering pattern
obtained from the other samples (Fig. 6).
qPCR validation of expression
Twenty-two of the most differentially expressed miRNAs after
HFD feeding, as revealed by our microRNA profiling, were also
tested by qPCR. After normalizing the expression levels with the
corresponding geometric mean value of the reference genes U6
snRNA, mmu-miR-191, mmu-miR-423-5p, mmu-miR-361 and
mmu-miR-103, the samples were checked for outliers to be
excluded. The qPCR verified the expression profile of the 22 DE
miRNAs. The fold changes were calculated using the DDCt
comparative quantification method. Data were corrected for assay
specific PCR efficiency (microRNA or endogenous control) and
normalized with a normalization factor based on the five validated
endogenous controls. Mmu-miR-141 was not detected in the SD
mice (control), hence no fold change was calculated. The relative
miRNA expression levels for each miRNA are depicted in Figure 7.
Moreover, we performed HCL and PCA analysis for the qPCR
validation data of 18 miRNAs (Fig. 8). The clustering results were
similar to those acquired by the microarray data.
Correlation between microrray and qPCR results
We identified an agreement between the microarray and the
qPCR results, showing the relative expression of array data
compared to the relative expression of qPCR data (Fig. 9A). The
relative expressions were based on three technical replicates. The
Pearson correlation value between microarray and qPCR data was
0.888 (Fig. 9B).
Gene Ontology (GO)
GO analysis was performed in order to approach the
functionality of the target genes of the studied miRNAs. Firstly,
the validated target genes of the differentially expressed miRNAs
were identified using the miRWalk algorithms shown in Table S1,
which is divided into the up- and the down-regulated miRNAs.
GO analysis was initially performed for the target genes of the up-
regulated miRNAs and then for the down-regulated ones. The
genes were initially separated into three groups, based on their
molecular function, biological process and cellular component.
The enriched processes of the up-regulated miRNA targets, along
with their statistical significance, are depicted in Figure 10. Cell
differentiation (adjP=1.41e-30) and metabolic processes (regula-
tion of metabolic process, adjP=1.85e-25) are among the most
significant biological processes related to the development of
obesity. Table S2 includes the genes that participate in all the
depicted enriched processes. Figure 11 exhibits the enriched
processes for the target genes of the down-regulated miRNAs.
Again the enrichment of processes related to obesity, such as
regulation of metabolic process (adjP=3.21e-25) or cell differen-
tiation (adjP=4.89e-35), is high. Table S3 depicts the genes that
participate in all the depicted enriched processes.
Discussion
The current study investigated the changes that occur in
miRNA expression in the adipose tissue, in mice after a long-term
(5-month) HFD-induced obesity. For this purpose, we performed
miRNA profiling and qPCR validation of our results. The
expression of some miRNAs was found either increased or
decreased in HFD-fed mice, compared to their SD-fed counter-
parts. Some of the results are in accordance with previous studies,
such as the up-regulation of mmu-miR-221 and mmu-miR222
cluster and the down-regulation of the mmu-miR-200 family, as
well as of mmu-miR-204, mmu-miR-30a*, mmu-miR-193, mmu-
miR-378 and mmu-miR-30e*. These findings have also been
confirmed in other independent studies. Their importance lies in
that they suggest new miRNA players in the field of obesity.
However, further in vivo and in vitro experimental investigation is
warranted in order to describe them as potential pharmaceutical
targets.
The rest of the differentially expressed miRNAs, after HFD
feeding, has not been previously reported, regarding adipogenesis
and obesogenesis. These include on the one hand the up-regulated
miRNAs: mmu-miR-342-3p, mmu-miR-142-3p, mmu-miR-142-
5p, mmu-miR-21, mmu-miR-335-5p, mmu-miR-146a, mmu-
miR-146b, mmu-miR-674 and mmu-miR-379; and on the other
hand the down-regulated ones after HFD-induced obesity: mmu-
miR-122, mmu-miR-133p, mmu-miR-1, mmu-miR-30a, mmu-
miR-192 and mmu-miR-203.
To get a deeper insight into the potential functional significance
of the differentially expressed miRNAs in white adipose tissue,
their validated target genes were identified using the miRWalk
algorithm. Then, Gene Ontology analysis classified the potential
enriched functions of these genes in groups. A single miRNA is
likely to regulate many genes and each target gene may be
regulated by more than one miRNAs, as revealed by the miRWalk
algorithm. Therefore, the potential network of miRNAs and genes
that are involved in adipose tissue during HFD-induced obesity
seems to be highly complicated. Nevertheless, special focus was
given to certain highly enriched functions related to obesity and
adipogenesis.
Firstly, a significant function of the differentially expressed
miRNA targets is cell differentiation and the regulation of cell
differentiation (Figs.10, 11). This is linked to the fact that obesity is
characterized of both hypertrophy (enlargement of the existing
adipocytes) and hyperplasia (adipogenesis or adipocyte differenti-
ation) [28]. It is also important to point out that miRNAs that are
induced during adipogenesis, are usually repressed during obesity
development [19].
The mmu-miR-142-5p-regulated genes, Bmp-4 and Fgf10, are
involved in adipogenesis regulation [29]. Furthermore, Akt1, a
target of mmu-miR-142-3p, is also involved in this regulation [30].
Both mmu-miR-142-3p and mmu-miR-142-5p derive from the
stem loop precursor of mmu-miR-142. This is the first study to
Figure 10. GO terms annotation of the validated target genes of the up-regulated mmu-miRNAs after HFD feeding. The most
significant functions of the enriched miRNAs are highlighted in red color.
doi:10.1371/journal.pone.0034872.g010
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ments are warranted to elucidate its role in this process.
Mmu-miR-21 and mmu-miR-146a are also potentially involved
in adipocyte differentiation by targeting C/EBP beta [31] and
ApoE, respectively [32]. Mmu-miR-146a, which shares 91%
homology with mmu-miR-146b in a length of 22 nt [33], is mainly
implicated in inflammatory response by being induced by NFkB
[34] and by targeting interferon gamma (as revealed by miRWalk
in this study). In contrast with mmu-miR-21 for which there are
studies describing it to increase during adipocyte differentiation
[35,36], no reference is available regarding mmu-miR-146a,
mmu-miR-146b and obesity. Taking into account the up-
regulation of mmu-miR-21, mmu-miR-146a and mmu-miR-
146b after HFD-induced obesity in the present study, these
miRNAs are suggested as a research subject for future studies in
obesity.
Mmu-miR-222 also belongs to the miRNA group being highly
enriched during adipogenesis. It has already been shown to be up-
regulated in obesity and down-regulated in adipogenesis [19,37].
Hif-1a and TNF-a are two potential mmu-miR-222 targets
participating in the regulation of cell differentiation. Both genes
have been described to be indirectly implicated in adipogenesis
[38,39].
Mmu-miR-342-3p and mmu-miR-379 were both found to be
up-regulated after HFD-induced obesity in the present study.
These miRNAs have not been described before with relevance to
adipogenesis and obesity. A possible link between mmu-miR-342-
3p and obesity is the glucagon that is a potential target of this
miRNA and is implicated in obesogenesis [40]. Further studies are
needed to clarify any potential role of these miRNAs in these
processes.
Next, focus was given on the enriched process ‘‘regulation of
metabolic process’’. Mmu-miR-200b and mmu-miR-200c(mem-
bers of the mmu-miR-200 family), mmu-miR-203 and mmu-miR-
192 target Zeb1 and Zeb2 that regulate epithelial to mesenchymal
transition [41] and have recently been implicated in adipogenesis
and obesity [42]. The down-regulation of mmu-miR-200b and
mmu-miR-200c after HFD-induced obesity, is in accordance with
a previous study which showed that the mmu-miR-200 family
promotes adipogenesis [43]. The down-regulation of mmu-miR-
203 and mmu-miR-192 is described for the first time and warrants
further elucidation.
Of the down-regulated miRNAs after HFD-induced obesity, the
putative targets of mmu-miR-1, mmu-miR-204 and mmu-miR-
133b, are implicated in cell differentiation. Mmu-miR-1 has
mainly been characterized as a muscle-specific miRNA [44] and it
has been found to be expressed in brown adipocytes [45]. This is
in accordance with the theory that brown adipocytes and muscle
share common precursor cells. Mmu-miR-1 targets UCP-1, which
uncouples oxidative phosphorylation from the production of ATP
in brown adipocytes and energy is dissipated as heat [46]. The
expression of mmu-miR-1 that we detected in white adipose tissue,
can be due to the presence of brown adipocytes in white adipose
tissue [47] and may be important in the metabolic adaptation that
occurs in the mouse during HFD-feeding. Mmu-miR-204 and
mmu-miR-133b target Runx2 which promotes osteogenesis and
represses adipogenesis [48]. Mmu-miR-204 has already been
described to promote adipogenesis and repress osteogenesis
through Runx2 repression [49].
The down-regulation of mmu-miR-30a*, mmu-miR-30e*,
mmu-miR-193 and mmu-miR-378 during HFD-induced obesity
is consistent with previous studies [19,37,50]. This indicates that
these miRNAs should be further studied, so as to check if they can
successfully be targets for obesity treatment. On the other hand,
the down-regulation of mmu-miR-122 and mmu-miR-130a
during HFD-induced obesity that we report has not been
described before. Mmu-miR-122 is mainly expressed in the liver
and makes up for the 70% of all the liver miRNAs [51]. It is
known to be implicated in cholesterol biosynthetic pathway and
fatty acid metabolism [52]. Its expression in adipose tissue has
been found to be 200-fold less than in liver [53] and further
characterization of its potential role in obesogenesis is warranted.
Similarly, mmu-miR-130a is known to be a pro-angiogenic
miRNA and its role in adipose tissue has not been described
before [54]. Taking these data into account, it seems that miRNAs
play a regulatory role in the development of obesity. The present
study confirms the results of previous reports with reference to the
differential expression of miRNAs, after HFD feeding and during
adipogenesis. Moreover, we present novel miRNAs which are
involved in the aforementioned processes. Their exact role
remains to be further investigated, so as to come to a conclusion
regarding their usefulness as therapeutical targets for the
prevention and treatment of obesity, diabetes type 2 and metabolic
syndrome.
Supporting Information
Figure S1 Densities of individual-channel intensities for
two-color microarray data for all slides. The density plot
shows the effect of the normalization as the signal distribution of
the two channels is more similar after normalization than before.
(Hy3; green, Hy5; red).
(TIF)
Figure S2 Box plots illustrating the distribution of
signals measured on the capture probes before and
after normalization. The box-plots show that the majority of
capture probes have similar signals in both channels suggesting
that the miRNAs have similar expression levels in the paired
samples on each slide (Capture probes with a log2 median ratio of
‘‘0’’ on the Y-axis correspond to miRNAs that are equally
expressed in the 2 different samples on this slide). The lower
boundary of the box indicates the 25
th percentile, the line within
the box shows the median, and the upper edge of the box marks
the 75
th percentile. Whiskers above and below each box indicate
the 95
th and 5
th percentiles. All data points that lie outside the 5
th
and 95
th percentiles are shown as symbols.
(TIF)
Figure S3 The positive effect from normalization is
illustrated on each slide with an M-A plot before and
after normalization. After normalization the spots appear
symmetrically scattered around the horizontal line M=0. The
difference between the two channels (M) is now independent of the
average intensity level of the two channels. (slide 1-control 1, A;
control 2-sample 2, B; slide 3-sample, C)
(TIF)
Figure S4 Gene stability measurement (M) for endoge-
nous control genes. For every endogenous control gene, the
pair-wise variation with all other endogenous controls was
Figure 11. GO terms annotation of the validated target genes of the down-regulated mmu-miRNAs after HFD feeding. The most
significant functions of the enriched miRNAs are highlighted in red color.
doi:10.1371/journal.pone.0034872.g011
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1.5 was recommended and genes with expression stability above
1.5 were considered unstable across the samples and unsuitable for
endogenous controls in this experiment. U6 snRNA, mmu-191,
mmu-423-5p, mmu-361 and mmu-103 were considered accept-
able and used for normalization. The gene 5S rRNA was unstable
across the samples and therefore excluded from the normalization.
(TIF)
Figure S5 Weight measurements of mice before and
after HFD feeding (5 months). Wild type mice were fed a SD
or a HFD diet for 5 months. At the beginning of the experiment
the two groups of mice had no difference in their weights. After 5
months on SD or HFD, the mice of the HFD group were
significantly heavier than those of the SD group, as expected. Data
show mean6SEM values. N=8 for each diet type. *p,0.0001.
SD; standard diet, HFD; high-fat diet.
(TIF)
Figure S6 Wild type mice fed a HFD for 5 months
become more insulin resistant and less glucose tolerant
than the SD-fed ones. Results from glucose and insulin
tolerance tests are shown at the beginning of the experiment
(day 0) and after 5 months on SD or HFD feeding. Data show
means6SEM. N=8 for each diet type. *p,0.01, **p,0.001.
IPGTT: intraperitoneal glucose tolerance test, IPITT: intraperi-
toneal insulin tolerance test. SD; standard diet, HFD; high-fat diet.
(TIF)
Table S1 Upregulated and downregulated miRNAs with
their corresponding validated target genes based on
miRWalk algorithms
(XLS)
Table S2 Target genes of the upregulated miRNAs and
the enriched processes in which they participate.
(XLS)
Table S3 Target genes of the downregulated miRNAs
and the enriched processes in which they participate.
(XLS)
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